August 20, 2024 – Canary Global

Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials

First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System

Pioneering Gene and RNA Therapy

We are revolutionizing healthcare by harnessing the power of cutting-edge RNA and gene therapies to develop and deliver innovative treatments that improve the lives of individuals and families. We are committed to fostering a culture of scientific excellence and collaboration to create life-changing treatments that are safe, effective, and accessible to all.

Disclaimer: Canary Cure Therapeutics Inc’s website includes future planned care offerings, that are currently in development and are subject to regulatory approval before they are able to be commercialized

Day: 20 August 2024

Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials

Quick Links

Useful Links

Quick Contact

Follow Us